Medindia

X

Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 17, 2010 to Discuss Fourth Quarter 2009 Results

Wednesday, February 10, 2010 General News J E 4
Advertisement

WALTHAM, Mass., Feb. 10 /PRNewswire/ -- Inverness Medical Innovations, Inc. (NYSE: IMA), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release its fourth quarter 2009 earnings on Wednesday, February 17, 2010. The Company will also host a conference call beginning at 10:00 a.m. (Eastern Time) on that date to discuss these results and other corporate matters. During the conference call, the Company may discuss and answer questions concerning business and financial developments and trends. The Company's responses to questions, as well as other matters discussed during the conference call, may contain or constitute information that has not been disclosed previously.

The conference call may be accessed by dialing 706-679-1656 (domestic and international), an access code is not required, or via a link on the Inverness website at www.invmed.com.  It is also available via link at http://event.meetingstream.com/r.htm?e=184461&s=1&k=1A14C774F5FD857C8CEABC667F76C662.  An archive of the call will be available from the same link approximately two hours after the live call has concluded and will be accessible for 60 days.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life at home.  Inverness' global leading products and services, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health.  Inverness is headquartered in Waltham, Massachusetts.  

For additional information on Inverness Medical Innovations, please visit www.invmed.com.  

SOURCE Inverness Medical Innovations, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Raptor Pharmaceutical Corp. to Present Cystinosis ...
S
Increasing Competition From Other Biologic Agents ...